Investors

Midatech Pharma PLC (dual listed on LSE AIM: MTPH; and NASDAQ: MTP) is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines.

Shareholder Information

Date	Title	Document
21/05/21	Notice of 2021 AGM	Download
08/12/20	Notice of 2020 AGM	Download
12/02/20	Shareholder Circular and Notice of General Meeting to be held on 2 March 20	Download
19/06/19	Notice of 2019 AGM	Download
05/02/19	Shareholder Circular, Open Offer & Notice of General Meeting Panel Waiver	Download
28/09/18	Shareholder Circular and Notice of General Meeting to be held on 15 October 18	Download
13/08/18	Notice of 2018 AGM	Download
28/09/17	Notice of General Meeting to be held on 16 October 2017	Download
11/04/17	Notice of Annual General Meeting 2017	Download
12/10/16	Notice of General Meeting to be held on 28 October 2016	Download
11/05/16	Notice of 2016 AGM	Download
21/05/15	Notice of 2015 AGM	Download

Share Detail


Number of shares	98,468,387
Country of listing	UK / US
Status	AIM Listed / NASDAQ Listed
Index	FTSE AIM All Share / NASDAQ
FTSE Sector	Pharmaceutical & Biotechnology
FTSE sub-sector	Biotechnology
Ticker	MTPH / MTP
CUSIP	GB00BKT14T00

The percentage of 0.1p Ordinary shares not being held in public hands is 0.2%

Shares held in treasury: Nil.

There are no restrictions on the transfer of Ordinary shares in the Company.

Information correct as of 9 August 2021.

Major Shareholders

Midatech Pharma has been notified or is aware of the following holdings of more than 3% or more of the issued share capital of the Company.

Name	Number of shares	%
CMS Medical Venture Investment (HK) Limited*	5,194,805	5.3
A&B (HK) Company Limited*	5,194,805	5.3
Lombard Odier Asset Management (Europe) Limited	7,536,559	7.5